title: Response to letter regarding article, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis".
authors.affiliation: Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, QC, Canada.
authors.forename: Mitesh
authors.initials: M
authors.lastname: Shah
authors.affiliation: Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, QC, Canada.
authors.forename: Meytal
authors.initials: M
authors.lastname: Avgil Tsadok
authors.affiliation: Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, California, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, University Health Network, Toronto, ON, Canada.
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Jackevicius
authors.affiliation: Division of Cardiology, McGill University Health Center, Montreal, QC, Canada.
authors.forename: Vidal
authors.initials: V
authors.lastname: Essebag
authors.affiliation: Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University, Montreal, QC, Canada.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Eisenberg
authors.affiliation: Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, QC, Canada.
authors.forename: Elham
authors.initials: E
authors.lastname: Rahme
authors.affiliation: Division of Cardiology, University of British Columbia, Vancouver, BC, Canada.
authors.forename: Karin H
authors.initials: KH
authors.lastname: Humphries
authors.affiliation: Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
authors.forename: Jack V
authors.initials: JV
authors.lastname: Tu
authors.affiliation: Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, QC, Canada.
authors.forename: Hassan
authors.initials: H
authors.lastname: Behlouli
authors.affiliation: Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
authors.forename: Helen
authors.initials: H
authors.lastname: Guo
authors.affiliation: Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Center, Montreal, QC, Canada.
authors.forename: Louise
authors.initials: L
authors.lastname: Pilote
mesh_terms: D001281:Atrial Fibrillation / Q000453:epidemiology*; D005260:Female; D006470:Hemorrhage / Q000453:epidemiology*; D006801:Humans; D008297:Male; D011159:Population Surveillance; D006435:Renal Dialysis; D020521:Stroke / Q000453:epidemiology*; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D014859:Warfarin